Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Arpaia

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Current Opinion in Virology|March 24, 2012
Toll-like receptors: key players in antiviral immunityNicholas Arpaia, Gregory M Barton
Current Opinion in Microbiology|January 8, 2013
The impact of Toll-like receptors on bacterial virulence strategiesNicholas Arpaia, Gregory M Barton
Immunity|August 23, 2018
Treg Cells: A LAGging Hand Holds the Double-Edged Sword of the IL-23 AxisLucille C Rankin, Nicholas Arpaia
Science Immunology|October 21, 2018
Glycans for goodKatherine A Kaiser, Nicholas Arpaia
Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology|June 4, 2011
The metabolic effects of low-carbohydrate diets and incorporation into a biochemistry courseWendy Pogozelski, Nicholas Arpaia, Salvatore Priore
Nature Cancer|June 4, 2026
Bacterial engineering for cancer therapyNoah Chen, Zaofeng Yang, Nicholas Arpaia
Science (New York, N.Y.)|November 24, 2022
Engineering bacteria as interactive cancer therapiesCandice R Gurbatri, Nicholas Arpaia, Tal Danino
European Journal of Cancer (Oxford, England : 1990)|April 28, 2023
Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development targeting mucosal immunityRainjade Chung, James McKiernan, Nicholas Arpaia, et al.
The Journal of Experimental Medicine|April 26, 2024
Treg-tissue cell interactions in repair and regenerationLucas F Loffredo, Thomas M Savage, Olivia R Ringham, et al.
The Journal of Experimental Medicine|October 18, 2017
A nonimmune function of T cells in promoting lung tumor progressionJesse A Green, Nicholas Arpaia, Michail Schizas, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Current Opinion in Virology|March 24, 2012
Toll-like receptors: key players in antiviral immunityNicholas Arpaia, Gregory M Barton
Current Opinion in Microbiology|January 8, 2013
The impact of Toll-like receptors on bacterial virulence strategiesNicholas Arpaia, Gregory M Barton
Immunity|August 23, 2018
Treg Cells: A LAGging Hand Holds the Double-Edged Sword of the IL-23 AxisLucille C Rankin, Nicholas Arpaia
Science Immunology|October 21, 2018
Glycans for goodKatherine A Kaiser, Nicholas Arpaia
Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology|June 4, 2011
The metabolic effects of low-carbohydrate diets and incorporation into a biochemistry courseWendy Pogozelski, Nicholas Arpaia, Salvatore Priore
Nature Cancer|June 4, 2026
Bacterial engineering for cancer therapyNoah Chen, Zaofeng Yang, Nicholas Arpaia
Science (New York, N.Y.)|November 24, 2022
Engineering bacteria as interactive cancer therapiesCandice R Gurbatri, Nicholas Arpaia, Tal Danino
European Journal of Cancer (Oxford, England : 1990)|April 28, 2023
Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development targeting mucosal immunityRainjade Chung, James McKiernan, Nicholas Arpaia, et al.
The Journal of Experimental Medicine|April 26, 2024
Treg-tissue cell interactions in repair and regenerationLucas F Loffredo, Thomas M Savage, Olivia R Ringham, et al.
The Journal of Experimental Medicine|October 18, 2017
A nonimmune function of T cells in promoting lung tumor progressionJesse A Green, Nicholas Arpaia, Michail Schizas, et al.
Pageof 5